Animal Health Solutions

Q4 2021

Animal Health Solution - a Covetrus magazine for veterinary professionals

Issue link: https://www.e-digitaleditions.com/i/1422254

Contents of this Issue

Navigation

Page 30 of 59

UPGRADE TO Interceptor ® Plus (milbemycin oxime/praziquantel) covers all 5 major worms, including tapeworm and whipworm—unlike Heartgard Plus. With the flea and tick efficacy of Credelio or Seresto, that's 360-degree parasite protection. INTERNAL PARASITE PROTECTION EXTERNAL PARASITE PROTECTION NexGard ® (afoxolaner) FLEAS TICKS Heartgard ® Plus (ivermectin/pyrantel) HEARTWORM DISEASE TAPEWORMS WHIPWORMS HOOKWORMS ROUNDWORMS *A. caninum † A. caninum, U. stenocephala, A. braziliense * † OR ASK YOUR ELANCO SALES REPRESENTATIVE ABOUT PRESCRIBING 360-DEGREE PARASITE PROTECTION FOR YOUR CLIENTS Interceptor Plus Indications Interceptor Plus is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of adult roundworm (Toxocara canis, Toxascaris leonina), adult hookworm (Ancylostoma caninum), adult whipworm (Trichuris vulpis), and adult tapeworm (Taenia pisiformis, Echinococcus multilocularis, Echinococcus granulosus and Dipylidium caninum) infections in dogs and puppies 6 weeks of age or older and 2 pounds of body weight or greater. Interceptor Plus Important Safety Information Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Prior to administration of Interceptor Plus, dogs should be tested for existing heartworm infections. The safety of Interceptor Plus has not been evaluated in dogs used for breeding or in lactating females. The following adverse reactions have been reported in dogs after administration of milbemycin oxime or praziquantel: vomiting, diarrhea, depression/lethargy, ataxia, anorexia, convulsions, weakness, and salivation. For full prescribing information see Interceptor Plus package insert. Credelio Indications Credelio kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick) and Rhipicephalus sanguineus (brown dog tick)] for one month in dogs and puppies 8 weeks of age and older and weighing 4.4 pounds or greater. Credelio Important Safety Information Lotilaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving this class of drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. The safe use of Credelio in breeding, pregnant or lactating dogs has not been evaluated. The most frequently reported adverse reactions are weight loss, elevated blood urea nitrogen, polyuria, and diarrhea. For full prescribing information see Credelio package insert. 1 Adolph C, Barnett S, Beall M, et al. Diagnostic strategies to reveal covert infections with intestinal helminths in dogs. Vet Parasitol. 2017;247:108. 2 Dryden M, Herrin B, Payne P, et al. Further comparison of centrifugation versus passive fecal flotation for the recovery of Toxocara canis, Trichuris vulpis and Ancylostoma caninum eggs. 27th Conference of the WAAVP. Madison, WI; 2019:49. 7-11 July 2019. 3 Stafford K, Kollasch M, Duncan KT, et al. Detection of gastrointestinal parasitism at recreational canine sites in the United States (the DOGPARCS study). Parasite Vector. 2020;13:275. 4 Companion Animal Parasite Council. Trichuris vulpis. Available at: https://capcvet.org/guidelines/trichuris-vulpis/. Accessed May 21, 2021. Credelio, Interceptor, Seresto, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. All other company and product names are trademarks of their respective owners. © 2021 Elanco or its affiliates.

Articles in this issue

Links on this page

Archives of this issue

view archives of Animal Health Solutions - Q4 2021